ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 132277 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 132277; 2) Community: the network communities that were significantly associated with the response to NSC 132277; 3) Molecule: the relationships between components within communities and NSC 132277; 4) MDR: the compounds that were significantly associated with the NSC 132277.

NSC Compound Enrichment Correlation
NSC 34924 Null 0.0399098711718627 0.38678018
NSC 138425 Kinamycin C 0.0430505868034761 0.21422394
NSC 163088 Benzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium, 5,6-dihydro-9,10-dimethoxy-, chloride (9CI) 0.0430505868034761 0.41273912
NSC 269721 Androstan-3-one, 17-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (5.alpha.,17.beta.)- 0.0430505868034761 0.33006744
NSC 295500 Camptothecin Derivative 0.0430505868034761 0.19204218
NSC 305782 2,4-Quinazolinediamine, 6-[[3-(trifluoromethyl)phenyl]thio]- 0.0430505868034761 0.51272309
NSC 30916 MP 317 0.0430505868034761 0.21588671
NSC 331121 NIVEUSIN A 0.0430505868034761 0.1673114
NSC 366241 Ditercalinium dimethanesulfonate dimethanesulfonate 0.0430505868034761 0.41007725
NSC 376739 5,12-Naphthacenedione, 10-[(2,6-dideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- 0.0430505868034761 0.31370164
Total:86  Current:72    [First] [Prev] [Next] [Last]